益生菌治疗肠易激综合征随机对照试验的系统评价_《中国循证医学杂志》

作者：

舒小闯 , 周淑萍 , 陈春燕 , 王少东 ,  汪芳裕

南京大学医学院临床学院（南京军区南京总医院）消化内科（南京 210002）;

关键词：

益生菌肠易激综合征 Meta分析系统评价随机对照试验

DOI：

10.7507/1672-2531.20120128

视频：

导出 下载 收藏 扫码 引用

摘要 全文 图表 视频 参考文献 施引文献 补充材料

目的　系统评价益生菌治疗肠易激综合征（IBS）的疗效。
方法　计算机检索PubMed、Cochrane Library、Web of Sicence、EMbase、MD Consult、CNKI、CBM、WanFang Data中关于益生菌与安慰剂对照治疗IBS的随机对照试验。文献检索时限均从建库至2011年6月。由两名研究者按照Cochrane 系统评价员手册5.0.1标准独立评价文献质量、提取资料并交叉核对后，使用RevMan 5.1软件进行Meta分析。
结果　共纳入20个随机对照试验，1 713例患者。Meta分析结果显示：益生菌与安慰剂相比，在改善IBS总体症状、腹痛/腹部不适、腹胀方面，两组差异均有统计学意义。
结论　现有证据表明，益生菌对改善IBS症状有一定疗效。但由于纳入研究的方法学质量及各研究间诊断标准、评价方法、剂量、疗程等诸多方面存在差异，上述结论还需更多设计严格的高质量RCT进一步证实。

引用本文： 舒小闯,周淑萍,陈春燕,王少东,汪芳裕. 益生菌治疗肠易激综合征随机对照试验的系统评价. 中国循证医学杂志, 2012, 12(7): 840-847. doi: 10.7507/1672-2531.20120128 复制

1.	熊理守, 陈旻湖, 陈惠新, 等. 广东省社区人群肠易激综合征的流行病学研究. 中华医学杂志, 2004, (4): 18-21.
2.	中华医学会消化病学分会胃肠动力学组. 肠易激综合征诊断和治疗的共识意见 (2007, 长沙). 中华消化杂志, 2008, 28(1): 3.
3.	Nobaek S, Johansson ML, Molin G, et al. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol, 2000, 95(5): 1231-1238.
4.	O’Sullivan MA, O’Morain CA. Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig Liver Dis, 2000, 32(4): 294-301.
5.	Kim HJ, Camilleri M, Mckinzie S, et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther, 2003, 17(7): 895-904.
6.	Kajander K, Hatakka K, Poussa T, et al. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther, 2005, 22(5): 387-394.
7.	Kim HJ, Vazquez RM, Camilleri M, et al. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil, 2005, 17(5): 687-696.
8.	Niv E, Naftali T, Hallak R, et al. The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome--a double blind, placebo-controlled, randomized study. Clin Nutr, 2005, 24(6): 925-931.
9.	O’Mahony L, Mccarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology, 2005, 128(3): 541-551.
10.	Whorwell PJ, Altringer L, Morel J, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol, 2006, 101(7): 1581-1590.
11.	Guyonnet D, Chassany O, Ducrotte P, et al. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther, 2007, 26(3): 475-486.
12.	Andriulli A, Neri M, Loguercio C, et al. Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: a multicenter, randomized study. J Clin Gastroenterol, 2008, 42 Suppl 3 Pt 2(8): S218-S223.
13.	Drouault-Holowacz S, Bieuvelet S, Burckel A, et al. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroenterol Clin Biol, 2008, 32(2): 147-152.
14.	Kajander K, Myllyluoma E, Rajilic-Stojanovic M, et al. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther, 2008, 27(1): 48-57.
15.	Sinn DH, Song JH, Kim HJ, et al. Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome. Dig Dis Sci, 2008, 53(10): 2714-2718.
16.	Williams EA, Stimpson J, Wang D, et al. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. Aliment Pharmacol Ther, 2008, 29(1): 97-103.
17.	Agrawal A, Houghton LA, Morris J, et al. Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Aliment Pharmacol Ther, 2009, 29(1): 104-114.
18.	Hong KS, Kang HW, Im JP, et al. Effect of probiotics on symptoms in korean adults with irritable bowel syndrome. Gut Liver, 2009, 3(2): 101-107.
19.	Simren M, Ohman L, Olsson J, et al. Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome - a randomized, double-blind, controlled study. Aliment Pharmacol Ther, 2010, 31(2): 218-227.
20.	Guglielmetti S, Mora D, Gschwender M, et al. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life - a double-blind, placebo-controlled study. Aliment Pharmacol Ther, 2011, 33(10): 1123-1132.
21.	Hong YS, Hong KS, Park MH, et al. Metabonomic understanding of probiotic effects in humans with irritable bowel syndrome. J Clin Gastroenterol, 2011, 45(5): 415-425.
22.	Sondergaard B, Olsson J, Ohlson K, et al. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial. Scand J Gastroenterol, 2011, 46(6): 663-672.
23.	Horvath A, Dziechciarz P, Szajewska H. Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther, 2011, 33(12): 1302-1310.
24.	Aragon G, Graham DB, Borum M, et al. Probiotic therapy for irritable bowel syndrome. Gastroenterol Hepatol (NY), 2010, 6(1): 39-44.

1. 熊理守, 陈旻湖, 陈惠新, 等. 广东省社区人群肠易激综合征的流行病学研究. 中华医学杂志, 2004, (4): 18-21.
2. 中华医学会消化病学分会胃肠动力学组. 肠易激综合征诊断和治疗的共识意见 (2007, 长沙). 中华消化杂志, 2008, 28(1): 3.
3. Nobaek S, Johansson ML, Molin G, et al. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol, 2000, 95(5): 1231-1238.
4. O’Sullivan MA, O’Morain CA. Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig Liver Dis, 2000, 32(4): 294-301.
5. Kim HJ, Camilleri M, Mckinzie S, et al. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther, 2003, 17(7): 895-904.
6. Kajander K, Hatakka K, Poussa T, et al. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther, 2005, 22(5): 387-394.
7. Kim HJ, Vazquez RM, Camilleri M, et al. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil, 2005, 17(5): 687-696.
8. Niv E, Naftali T, Hallak R, et al. The efficacy of Lactobacillus reuteri ATCC 55730 in the treatment of patients with irritable bowel syndrome--a double blind, placebo-controlled, randomized study. Clin Nutr, 2005, 24(6): 925-931.
9. O’Mahony L, Mccarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology, 2005, 128(3): 541-551.
10. Whorwell PJ, Altringer L, Morel J, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol, 2006, 101(7): 1581-1590.
11. Guyonnet D, Chassany O, Ducrotte P, et al. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther, 2007, 26(3): 475-486.
12. Andriulli A, Neri M, Loguercio C, et al. Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: a multicenter, randomized study. J Clin Gastroenterol, 2008, 42 Suppl 3 Pt 2(8): S218-S223.
13. Drouault-Holowacz S, Bieuvelet S, Burckel A, et al. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroenterol Clin Biol, 2008, 32(2): 147-152.
14. Kajander K, Myllyluoma E, Rajilic-Stojanovic M, et al. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther, 2008, 27(1): 48-57.
15. Sinn DH, Song JH, Kim HJ, et al. Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome. Dig Dis Sci, 2008, 53(10): 2714-2718.
16. Williams EA, Stimpson J, Wang D, et al. Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. Aliment Pharmacol Ther, 2008, 29(1): 97-103.
17. Agrawal A, Houghton LA, Morris J, et al. Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Aliment Pharmacol Ther, 2009, 29(1): 104-114.
18. Hong KS, Kang HW, Im JP, et al. Effect of probiotics on symptoms in korean adults with irritable bowel syndrome. Gut Liver, 2009, 3(2): 101-107.
19. Simren M, Ohman L, Olsson J, et al. Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome - a randomized, double-blind, controlled study. Aliment Pharmacol Ther, 2010, 31(2): 218-227.
20. Guglielmetti S, Mora D, Gschwender M, et al. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life - a double-blind, placebo-controlled study. Aliment Pharmacol Ther, 2011, 33(10): 1123-1132.
21. Hong YS, Hong KS, Park MH, et al. Metabonomic understanding of probiotic effects in humans with irritable bowel syndrome. J Clin Gastroenterol, 2011, 45(5): 415-425.
22. Sondergaard B, Olsson J, Ohlson K, et al. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial. Scand J Gastroenterol, 2011, 46(6): 663-672.
23. Horvath A, Dziechciarz P, Szajewska H. Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther, 2011, 33(12): 1302-1310.
24. Aragon G, Graham DB, Borum M, et al. Probiotic therapy for irritable bowel syndrome. Gastroenterol Hepatol (NY), 2010, 6(1): 39-44.

上一篇
甲状腺、甲状旁腺术后常规引流的系统评价
下一篇
局部用氟预防儿童龋齿的系统评价

《中国循证医学杂志》

益生菌治疗肠易激综合征随机对照试验的系统评价

摘要 全文 图表 视频 参考文献 施引文献 补充材料

上一篇

下一篇

Format

Content

《中国循证医学杂志》

益生菌治疗肠易激综合征随机对照试验的系统评价

摘要 全文 图表 视频 参考文献 施引文献 补充材料

上一篇

下一篇

Format

Content

摘要全文图表视频参考文献施引文献补充材料